[1]
M. Czarkowski, K. Raksa, E. Powroźniak, and K. Spozowski, “Impact of SGLT2 inhibitors treatment on the chronic kidney disease in people with type 2 diabetes”, J Educ Health Sport, vol. 12, no. 9, pp. 319–327, Sep. 2022.